Patent_application_number,Applicant_name,Year_of_application,Patent_system
EP2402445A1,NATIONAL RESEARCH COUNCIL CANADA,2012,EPO
EP2402448A2,DU PONT,2012,EPO
EP2403939A1,UNIV NANYANG TECH [SG],2012,EPO
EP2404994A1,OTSUKA PHARMACEUTICAL,2012,EPO
EP2404995A1,OTSUKA PHARMACEUTICAL,2012,EPO
EP2405003A1,NATIONAL RESEARCH COUNCIL CANADA,2012,EPO
EP2405004A1,NATIONAL RESEARCH COUNCIL CANADA,2012,EPO
EP2405007A1,DU PONT,2012,EPO
EP2405012A1,DU PONT,2012,EPO
EP2405014A1,IFF,2012,EPO
EP2407488A2,PROCELL THERAPEUTICS INC [KR]; JO DAEWOONG [KR],2012,EPO
EP2407542A1,NATIONAL RESEARCH COUNCIL CANADA,2012,EPO
EP2408795A1,DSM IP ASSETS BV,2012,EPO
EP2408797A2,DSM IP ASSETS BV,2012,EPO
EP2408922A1,DSM IP ASSETS BV,2012,EPO
EP2410061A1,SCHWARZ WOLFGANG,2012,EPO
EP2420253A1,LEADARTIS S L [ES],2012,EPO
EP2438173A2,UNIV OHIO STATE RES FOUND [US],2012,EPO
EP2439271A1,TORAY,2012,EPO
EP2440033A2,EVOGENE,2012,EPO
EP2441828A1,STAZIONE ZOOL ANTON DOHRN [IT],2012,EPO
EP2441832A1,JAPAN TOBACCO INC,2012,EPO
EP2441842A1,DU PONT,2012,EPO
EP2441843A1,DU PONT,2012,EPO
EP2450434A2,BASF,2012,EPO
EP2456875A1,GOVERNMENT OF CHINA,2012,EPO
EP2478008A2,"GRUBER DAVID [US], KAO HUNG-TEH [US], PIERIBONE VINCENT [US]",2012,EPO
EP2479272A1,AJINOMOTO,2012,EPO
EP2480680A1,CHEVRON,2012,EPO
EP2489729A2,UNIV LOMA LINDA [US],2012,EPO
EP2496696A1,AGENCY FOR SCIENCE TECHNOLOGY AMD RESEARCH,2012,EPO
EP2508610A1,BASF,2012,EPO
EP2519097A2,EVOGENE,2012,EPO
EP2519636A1,DSM IP ASSETS BV,2012,EPO
EP2522216A1,DU PONT,2012,EPO